1-8 of 8
Susannah Patarroyo-White
Close
Sort by
Journal Articles

BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice

Ekta Seth Chhabra, Tongyao Liu, John Kulman, Susannah Patarroyo-White, Buyue Yang, Qi Lu, Douglas Drager, Nancy Moore, Jiayun Liu, Amy M. Holthaus, Jurg M. Sommer, Ayman Ismail, Deana Rabinovich, Zhan Liu, Arjan van der Flier, Allison Goodman, Chris Furcht, Mark Tie, Tyler Carlage, Randy Mauldin, Terrence M. Dobrowsky, Zhiqian Liu, Oblaise Mercury, Lily Zhu, Baisong Mei, Volker Schellenberger, Haiyan Jiang, Glenn F. Pierce, Joe Salas, Robert Peters
Journal: Blood
Blood (2020) 135 (17): 1484–1496.
https://doi.org/10.1182/blood.2019001292
Published: 2020
Includes: Supplemental data
Journal Articles

A Novel Single Chain Recombinant Factor VIII Fc Fusion Protein Is Active In Vitro and Fully Efficacious in An In Vivo Hema Mouse Bleeding Model

Yang Buyue, PhD, Tongyao Liu, Thomas Reidy, Susannah Patarroyo-White, George D Kamphaus, PhD, Mark Slein, BS, Glenn F Pierce, M.D., PhD, Jurg M Sommer, PhD, Robert Peters, PhD
Journal: Blood
Blood (2011) 118 (21): 1192.
https://doi.org/10.1182/blood.V118.21.1192.1192
Published: 2011
Journal Articles

AV513 Promotes Tissue Factor-Mediated Coagulation in Fresh Human Whole Blood from Severe and Moderate Hemophilia a Subjects.

Jerry Sherman Powell, MD, Sabine Knappe, PhD, Janet A Harrison, BS, Susannah Patarroyo-White, BS, Kirk Johnson, PhD, Srinivasa Prasad, PhD
Journal: Blood
Blood (2008) 112 (11): 1223.
https://doi.org/10.1182/blood.V112.11.1223.1223
Published: 2008
Journal Articles

AV513 Enhances Tissue Factor Activity by Inhibiting TFPI in Hemophilia A Plasma: Potential TFPI Target Sites and Potentiation of Factor VIII Activity.

Sabine Knappe, PhD, Nicholas Kripalani, BS, Susannah Patarroyo-White, BS, Kirk W. Johnson, PhD, Srinivasa Prasad, PhD
Journal: Blood
Blood (2007) 110 (11): 497.
https://doi.org/10.1182/blood.V110.11.497.497
Published: 2007
Journal Articles

Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy

Haiyan Jiang, Linda B. Couto, Susannah Patarroyo-White, Tongyao Liu, Dea Nagy, Joseph A. Vargas, Shangzhen Zhou, Ciaran D. Scallan, Jurg Sommer, Sharmila Vijay, Federico Mingozzi, Katherine A. High, Glenn F. Pierce
Journal: Blood
Blood (2006) 108 (10): 3321–3328.
https://doi.org/10.1182/blood-2006-04-017913
Published: 2006
Journal Articles

Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs

Haiyan Jiang, David Lillicrap, Susannah Patarroyo-White, Tongyao Liu, Xiaobing Qian, Ciaran D. Scallan, Sandra Powell, Tracey Keller, Morag McMurray, Andrea Labelle, Dea Nagy, Joseph A. Vargas, Shangzhen Zhou, Linda B. Couto, Glenn F. Pierce
Journal: Blood
Blood (2006) 108 (1): 107–115.
https://doi.org/10.1182/blood-2005-12-5115
Published: 2006
Journal Articles

Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice

Ciaran D. Scallan, Haiyan Jiang, Tongyao Liu, Susannah Patarroyo-White, Jurg M. Sommer, Shangzhen Zhou, Linda B. Couto, Glenn F. Pierce
Journal: Blood
Blood (2006) 107 (5): 1810–1817.
https://doi.org/10.1182/blood-2005-08-3229
Published: 2006
Journal Articles

AAV8-Factor IX Hepatic Gene Transfer with Transient Immunosuppression Is Safe but Is Abrogated by Low Titers of Neutralizing Antibody in Rhesus Macaques.

Haiyan Jiang, PhD, Susannah Patarroyo-White, BS, Tongyao Liu, BS, Bin Yang, Ph.D, Dea Nagy, M.D, Lin He, M.D, Ciaran D. Scallan, Ph.D, Jurg Sommer, Ph.D, Shangzhen Zhou, M.D, Linda B. Couto, Ph.D, Katherine A. High, M.D, Glenn F. Pierce, M.D/Ph.D
Journal: Blood
Blood (2005) 106 (11): 5532.
https://doi.org/10.1182/blood.V106.11.5532.5532
Published: 2005